| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 9 |
| GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: Q4QF33
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 105 | 107 | PF00675 | 0.631 |
| CLV_PCSK_FUR_1 | 106 | 110 | PF00082 | 0.629 |
| CLV_PCSK_KEX2_1 | 105 | 107 | PF00082 | 0.617 |
| CLV_PCSK_KEX2_1 | 108 | 110 | PF00082 | 0.604 |
| CLV_PCSK_PC1ET2_1 | 108 | 110 | PF00082 | 0.611 |
| DOC_MAPK_gen_1 | 105 | 113 | PF00069 | 0.459 |
| DOC_USP7_MATH_1 | 5 | 9 | PF00917 | 0.623 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.605 |
| LIG_FHA_1 | 59 | 65 | PF00498 | 0.368 |
| LIG_FHA_2 | 95 | 101 | PF00498 | 0.487 |
| LIG_LIR_Gen_1 | 47 | 57 | PF02991 | 0.474 |
| LIG_LIR_Gen_1 | 8 | 18 | PF02991 | 0.596 |
| LIG_LIR_Nem_3 | 47 | 52 | PF02991 | 0.480 |
| LIG_LIR_Nem_3 | 67 | 71 | PF02991 | 0.362 |
| LIG_LIR_Nem_3 | 8 | 13 | PF02991 | 0.587 |
| LIG_SH2_CRK | 10 | 14 | PF00017 | 0.584 |
| LIG_SH2_STAT5 | 49 | 52 | PF00017 | 0.331 |
| LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.395 |
| LIG_SH3_3 | 109 | 115 | PF00018 | 0.485 |
| LIG_SH3_3 | 89 | 95 | PF00018 | 0.480 |
| LIG_TRAF2_1 | 97 | 100 | PF00917 | 0.496 |
| LIG_UBA3_1 | 117 | 124 | PF00899 | 0.422 |
| MOD_CK2_1 | 94 | 100 | PF00069 | 0.490 |
| MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.445 |
| MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.404 |
| MOD_GlcNHglycan | 7 | 10 | PF01048 | 0.433 |
| MOD_GSK3_1 | 1 | 8 | PF00069 | 0.644 |
| MOD_GSK3_1 | 22 | 29 | PF00069 | 0.681 |
| MOD_GSK3_1 | 37 | 44 | PF00069 | 0.565 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.727 |
| MOD_NEK2_1 | 64 | 69 | PF00069 | 0.470 |
| MOD_NEK2_2 | 9 | 14 | PF00069 | 0.573 |
| MOD_Plk_4 | 26 | 32 | PF00069 | 0.652 |
| MOD_Plk_4 | 64 | 70 | PF00069 | 0.425 |
| TRG_ENDOCYTIC_2 | 10 | 13 | PF00928 | 0.587 |
| TRG_ENDOCYTIC_2 | 49 | 52 | PF00928 | 0.331 |
| TRG_NLS_MonoCore_2 | 105 | 110 | PF00514 | 0.429 |
| TRG_NLS_MonoExtN_4 | 105 | 111 | PF00514 | 0.438 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P7L8 | Leptomonas seymouri | 73% | 96% |
| A0A0S4JKC2 | Bodo saltans | 41% | 100% |
| A0A1X0NUC2 | Trypanosomatidae | 57% | 89% |
| A0A3R7MID2 | Trypanosoma rangeli | 55% | 90% |
| A0A3S5H6W1 | Leishmania donovani | 97% | 100% |
| A4H8B4 | Leishmania braziliensis | 83% | 100% |
| A4HWN4 | Leishmania infantum | 95% | 100% |
| E9AQE2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |